Division of Cardiovascular Surgery, Department of Surgery, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada.
Ann Thorac Surg. 2012 Mar;93(3):840-8. doi: 10.1016/j.athoracsur.2011.10.032. Epub 2012 Jan 26.
We investigated the natural history, outcomes of myectomy, and impact on survival of obstructive hypertrophic cardiomyopathy (HCM) in childhood.
All 120 children diagnosed with HCM between 1971 and 2006 were studied. Available echocardiograms (n=685) were incorporated in regression analyses adjusted for repeated measures. Multiphase parametric models and competing risks methodology were used to define outcomes.
Left ventricular outflow tract (LVOT) obstruction (peak gradient>30 mm Hg) developed in 61 (50%) of the cohort. Onset of obstructive features occurred during 2 discrete periods of risk; either during infancy (within 3 years of age), or otherwise later during early adolescence and beyond. Among children with obstructive HCM, the following 2 distinct groups were apparent: (1) those with peak LVOT gradients less than 65 mm Hg showed hemodynamic improvement (p<0.001) with medical strategies; and (2) those with peak gradients greater than 65 mm Hg instead had accelerated septal hypertrophy (p<0.001) with progression of peak gradients (p<0.01), and therefore underwent myectomy. Myectomy restored the gradient (mean 57 mm Hg reduction, 95% confidence interval 25 to 88, p<0.01) to nonobstructive levels. Furthermore, peak gradients and septal hypertrophy did not progress thereafter; they instead mirrored the natural history of nonobstructive HCM. Overall, in our experience, obstructive disease (or need for myectomy) did not influence late risk of death compared with children with nonobstructive HCM.
Obstructive HCM is phenotypically heterogeneous in childhood. Peak gradients less than 65 mm Hg respond well to nonsurgical management. The patient subset with higher gradients (>65 mm Hg) instead responds poorly and early myectomy should be pursued. Reassuringly, late survival in this cohort was not compromised by development of obstructive symptoms.
我们研究了儿童梗阻性肥厚型心肌病(HCM)的自然病史、心肌切除术的结果以及对生存的影响。
研究了 1971 年至 2006 年间诊断为 HCM 的 120 名儿童。将可获得的超声心动图(n=685)纳入调整了重复测量的回归分析中。多相参数模型和竞争风险方法用于定义结果。
61 名(50%)队列患儿出现左心室流出道(LVOT)梗阻(峰值梯度>30mmHg)。梗阻特征的发生发生在 2 个不同的风险期;要么在婴儿期(3 岁以内),要么在青春期早期及以后。在梗阻性 HCM 患儿中,有以下 2 个明显的亚组:(1)LVOT 梯度小于 65mmHg 的患儿,经药物治疗后血流动力学得到改善(p<0.001);(2)LVOT 梯度大于 65mmHg 的患儿则出现室间隔肥厚加速(p<0.001),峰值梯度进展(p<0.01),因此行心肌切除术。心肌切除术将梯度(平均降低 57mmHg,95%置信区间 25 至 88,p<0.01)恢复到非梗阻水平。此外,此后峰值梯度和室间隔肥厚不再进展;相反,它们反映了非梗阻性 HCM 的自然病史。总的来说,根据我们的经验,与非梗阻性 HCM 患儿相比,梗阻性疾病(或需要心肌切除术)并不影响晚期死亡率。
儿童梗阻性 HCM 表型异质性。梯度小于 65mmHg 的患儿对非手术治疗反应良好。梯度较高(>65mmHg)的患者亚组反应不佳,应早期行心肌切除术。令人放心的是,该队列的晚期生存率并未因梗阻症状的发展而受到影响。